JP2023544633A5 - - Google Patents
Info
- Publication number
- JP2023544633A5 JP2023544633A5 JP2023521740A JP2023521740A JP2023544633A5 JP 2023544633 A5 JP2023544633 A5 JP 2023544633A5 JP 2023521740 A JP2023521740 A JP 2023521740A JP 2023521740 A JP2023521740 A JP 2023521740A JP 2023544633 A5 JP2023544633 A5 JP 2023544633A5
- Authority
- JP
- Japan
- Prior art keywords
- homologous
- region
- nucleotide sequence
- cells
- rag1
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2016139.4A GB202016139D0 (en) | 2020-10-12 | 2020-10-12 | Polynucleotide |
| GB2016139.4 | 2020-10-12 | ||
| AU2021202657A AU2021202657A1 (en) | 2021-04-28 | 2021-04-28 | Polynucleotide |
| AU2021202657 | 2021-04-28 | ||
| PCT/EP2021/078222 WO2022079054A1 (en) | 2020-10-12 | 2021-10-12 | Replacement of rag1 for use in therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023544633A JP2023544633A (ja) | 2023-10-24 |
| JP2023544633A5 true JP2023544633A5 (enExample) | 2024-10-22 |
Family
ID=78413971
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023521740A Pending JP2023544633A (ja) | 2020-10-12 | 2021-10-12 | 治療における使用のためのｒａｇ１の置き換え |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230365996A1 (enExample) |
| EP (1) | EP4225900A1 (enExample) |
| JP (1) | JP2023544633A (enExample) |
| AU (1) | AU2021359781A1 (enExample) |
| IL (1) | IL302031A (enExample) |
| WO (1) | WO2022079054A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4416171A1 (en) * | 2021-10-12 | 2024-08-21 | Ospedale San Raffaele S.r.l. | Polynucleotides useful for correcting mutations in the rag1 gene |
| GB202206346D0 (en) * | 2022-04-29 | 2022-06-15 | Ospedale San Raffaele Srl | Gene therapy |
| WO2025073293A1 (en) * | 2023-10-02 | 2025-04-10 | Consorcio Centro De Investigación Biomédica En Red | Gene editing methods for cd34+ cells to achieve clinically relevant efficacies |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2325003B (en) | 1996-10-17 | 2000-05-10 | Oxford Biomedica Ltd | Rectroviral vectors |
| WO2017134529A1 (en) * | 2016-02-02 | 2017-08-10 | Crispr Therapeutics Ag | Materials and methods for treatment of severe combined immunodeficiency (scid) or omenn syndrome |
| CN112601812A (zh) | 2018-06-25 | 2021-04-02 | 圣拉斐尔医院有限责任公司 | 基因疗法 |
-
2021
- 2021-10-12 IL IL302031A patent/IL302031A/en unknown
- 2021-10-12 US US18/030,711 patent/US20230365996A1/en active Pending
- 2021-10-12 WO PCT/EP2021/078222 patent/WO2022079054A1/en not_active Ceased
- 2021-10-12 JP JP2023521740A patent/JP2023544633A/ja active Pending
- 2021-10-12 EP EP21798950.8A patent/EP4225900A1/en active Pending
- 2021-10-12 AU AU2021359781A patent/AU2021359781A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7651190B2 (ja) | 遺伝子操作ｒｎａを用いた内因性ａｄａｒによる標的化ｒｎａ編集 | |
| US12065669B2 (en) | Methods and compositions for modulating a genome | |
| US20230242899A1 (en) | Methods and compositions for modulating a genome | |
| Toyonaga et al. | Organization and sequences of the diversity, joining, and constant region genes of the human T-cell receptor beta chain. | |
| US20220127621A1 (en) | Fusion proteins and fusion ribonucleic acids for tracking and manipulating cellular rna | |
| JP2024534523A5 (enExample) | ||
| JP2022500066A5 (enExample) | ||
| JP2022505402A5 (enExample) | ||
| JP2021520202A5 (enExample) | ||
| Odermatt et al. | Repeating modular structure of the fibronectin gene: relationship to protein structure and subunit variation. | |
| CN118416088A (zh) | 经由抑制性tRNAs和脱氨酶对突变进行RNA靶向 | |
| JP2006502748A5 (enExample) | ||
| CN117512014A (zh) | 酸性α-葡萄糖苷酶变体及其用途 | |
| JP2022553573A5 (enExample) | ||
| EP4277990A1 (en) | Targeted rna editing by leveraging endogenous adar using engineered rnas | |
| Renbaum et al. | Isolation and characterization of the full-length 3′ untranslated region of the human von Hippel-Lindau tumor suppressor gene | |
| JP2025521102A5 (enExample) | ||
| US20250312376A1 (en) | Compositions and methods for modulating a genome in t cells, induced pluripotent stem cells, and respiratory epithelial cells | |
| JP2023504826A5 (enExample) | ||
| JP2024534991A5 (enExample) | ||
| JP2024503091A5 (enExample) | ||
| CN116194578A (zh) | 通过靶向dux4基因来治疗面肩肱型肌营养不良症(fshd)的方法 | |
| WO2024083095A1 (zh) | 环状rna及载体和载体的应用 | |
| CN115552023A (zh) | 一种改良型慢病毒表达载体及其构建方法与应用 | |
| JP2024538769A5 (enExample) |